Nurse Practitioner in Monroe Township, NJ Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Michele Julia Mahmet-fox, A.N.P. Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 227 Old Forge Rd, Monroe Township, NJ 08831 Phone: 732-605-0004

Mrs. Nikha Rana Parmar, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 6 Greenwich Ct, Monroe Township, NJ 08831 Phone: 516-884-0225

Mesode Sobe-uduaghan, APRN Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 12 Cassandra Ct, Monroe Township, NJ 08831 Phone: 240-498-2207

Rose N Egbutu, Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 13 Bermuda Dunes Dr, Monroe Township, NJ 08831 Phone: 201-259-6325

Luanne B. Hill-goldberg, MSN, NP-C Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 18 Centre Dr, Suite 103, Monroe Township, NJ 08831 Phone: 609-655-1700    Fax: 609-655-4455

Ms. Samantha Ann Brocato, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 10 George Ave, Monroe Township, NJ 08831 Phone: 732-710-2702

News Archive

YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

YM BioSciences Inc., today announced that it has received positive opinions from the Committee for Orphan Medicinal Products of the European Commission to grant Orphan Medicinal Product Designation to its JAK1/JAK2 inhibitor, CYT387, for the treatment of primary myelofibrosis, post-polycythaemia vera myelofibrosis and post-essential thrombocythaemia myelofibrosis.

Medco announces new $3 billion share repurchase program

Medco Health Solutions, Inc. today announced that its Board of Directors has unanimously approved a new $3 billion share repurchase program.

Schiff Nutrition International third-quarter net sales increase to 53.3M

Schiff Nutrition International, Inc., today announced results for the fiscal 2010 third quarter and nine months ended February 28, 2010. The company also announced plans to return $0.50 per share to shareholders through a special cash dividend payable on April 14, 2010 to shareholders of record at the close of business on March 31, 2010.

Quality Systems enters into agreement to acquire Opus Healthcare Solutions

Quality Systems, Inc. ("QSI"), a leading provider of healthcare information systems and connectivity solutions, today announced that QSI has entered into an agreement to acquire Opus Healthcare Solutions, Inc.

FDA approves ORALAIR sublingual allergy immunotherapy tablet

GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.

Read more Medical News

› Verified 2 days ago